About this trial
Micro-osteoperforations (MOPs) cause cortical bone injuries and consequently increase the expression of inflammatory mediators, allowing for increased bone and periodontal ligament remodeling associated with orthodontic movement. It remains unclear the effect of orthodontic intrusion combined with MOPs application on teeth with reduced periodontium. The general objective will be to determine the efficacy of MOPs during orthodontic tooth movement (OTM) in terms of periodontal and orthodontic outcomes in stage IV periodontitis patients, case type 2 with pathological tooth migration (PTM), characterized the presence of at least one flared tooth of the upper-anterior sextant with an intrabony defect (intrabony component \<5mm)
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
adult patients older than 18-year-old;
systemically healthy (see
Disqualifiers
diagnosed as stage IV (Papapanou et al., 2018) case-type 2 (Herrera et al. 2022) periodontitis;
the presence of at least one flared tooth of the upper-anterior sextant with an intrabony defect (intrabonny component <5mm) (experimental teeth);
in need of orthodontic therapy.
systemic diseases (diabetes mellitus, obesity, cardiovascular diseases);
Trial design
Parallel
Treatments tested in this trial
Micro-ostoperforations (MOPs)
Procedure/Surgery3 MOPs will be performed in the bone next to the root of the experimental tooth. MOPs will be performed using the Excellerator® (Propel Orthodontics, Denstply, Sirona)
Treatment groups
Trial outcomes
Primary outcomes
CAL
clinical attachment level (CAL) in mm
Secondary outcomes
Type of movement
Description of the type of movement (categorical outcome)
Duration of orthodontic treatment
Total duration in months
External apical root resorption (EARR)
Presence of EARR (in mm3)
Probing pocket depth (PPD)
PPD in mm
Sponsors and contacts
Click on the lead sponsor to view all of their trials.